Study: Pfizer's COVID shot effective for people with chronic diseases
Clalit Research Institute study finds that the vaccine is 80% effective against symptomatic infection for people with heart or chronic kidney diseases, 86% for people with type 2 diabetes, 75% for cerebrovascular disease, and 84% for people suffering from immunodeficiency.









